Company profile
Sirona Biochem Corp.
OTC: SRBCF · Healthcare · Biotechnology
Canadian filerHQ Vancouver, BCReports USD
#1113 of 1,422 Healthcare companies by revenuebottom-decile growth
EA Score
——FH —DQ —GM —SS 41
v0.1 · 5/100 weight · pillars only
↑ listing tenure, disclosure history · ↓ revenue growth (YoY), operating margin
Methodology →Revenue TTM
-$12.1k
Rev growth YoY (TTM)
-119.3%
Net income (FY)
-$1.9M
Employees
10
as of 2026-08-25
Market cap
$1.6M
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$25.8k34.8k CAD2023
Net income-$1.9M-2.5M CAD2023
Operating income-$1.8M-2.4M CAD2023
Total assets$744.1k1.0M CAD2023
Liabilities$2.6M3.5M CAD2023
Equity-$1.8M-2.5M CAD2023
Revenue trend
FY2017 – FY2023 · USD
FY17
FY18
FY19
FY20
FY21
FY22
FY23
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Sirona Biochem Corp.’s revenue?
Sirona Biochem Corp. booked $25.8k in FY2023 revenue, contracting 95% year over year — among the slowest-growing Healthcare companies we track, at a -7312.4% net margin.
Peers · Healthcare
UMC, Inc.——Talphera, Inc.46DProteonomix, Inc.——Doseology Sciences Inc.40DSenti Biosciences, Inc.27DJupiter Neurosciences, Inc.18DKey facts
CEOHoward J. Verrico
SectorHealthcare
IndustryBiotechnology
HeadquartersVancouver, BC
ExchangeOTC: SRBCF
Employees10
IPO date2013-02-12
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.